Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide.

Transplant Cell Ther · 2021 · PMC8504778 · PMID 34537419

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The rate of grade III-IV aGVHD was also higher in the PB group than in the BM group (12% versus 7%), which, although clinically meaningful, did not reach statistical significance owing to the small number of events.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.